GlassScriptPhysician profile
Anthony C Gemayel
NPI 1568818490
$77,947.94
in general payments reported to CMS, 2019-2025
20 companies · $9,662 in 2025
The $9,662 reported for 2025 was more than what 76% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,101 · 2020: $642 · 2021: $29K · 2022: $30K · 2023: $1,481 · 2024: $3,453 · 2025: $9,662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,744 · Travel and Lodging: $4,635 · Food and Beverage: $2,218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,743.75 |
| Travel and Lodging | $4,635.32 |
| Food and Beverage | $2,218.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $69,907.43 | 2019-2025 | Real Intelligence, Journey II, Legion |
| Zimmer Biomet Holdings, INC. | $3,029.23 | 2019-2023 | Arcos, Persona, Mymobility Platform |
| Stryker Corporation | $1,929.66 | 2019-2025 | Mako, Triathlon |
| Pinnacle, INC | $1,319.25 | 2021 | |
| Medical Device Business Services, INC. | $549.98 | 2019-2020 | |
| Medtronic USA, INC. | $226.15 | 2019-2020 | |
| Depuy Synthes Sales INC. | $219.32 | 2019-2025 | Dynacord, Orthocord, Monovisc |
| Intellijoint Surgical INC. | $188.47 | 2022 | |
| Baxter Healthcare | $123.27 | 2019 | |
| Acumed LLC | $105.68 | 2023-2024 | Acumed, Inframe Implant, Innate Implant |
| Davol INC. | $80.97 | 2023-2025 | Arista Ah Flexitip, Arista |
| Globus Medical, INC. | $59.32 | 2019 | |
| Conformis, INC. | $46.06 | 2021 | |
| Nevro Corp. | $34.75 | 2023 | Senza |
| Averitas Pharma INC. | $29.53 | 2024 | Qutenza |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $28.26 | 2025 | Puraply Wound Matrix |
| Ethicon US, LLC | $20.11 | 2020 | |
| Sanara Medtech INC. | $20.11 | 2025 | Celleraterx |
| Vertex Pharmaceuticals Incorporated | $15.54 | 2025 | |
| Anika Therapeutics, INC. | $14.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Gemayel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.